Article

Test

-

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
ExSight Ventures invests in RevOpsis Therapeutics to further AMD treatment candidate
September 18th 2025

ExSight Ventures invests in RevOpsis Therapeutics to further AMD treatment candidate

3 Things You Should Know About the GA Pipeline
September 18th 2025

NK Insights: An Interactive Corneal Sensitivity Testing Workshop

Q&A: Andreas Pollreisz explains when to use and not use widefield OCT-A imaging
September 18th 2025

Q&A: Andreas Pollreisz explains when to use and not use widefield OCT-A imaging

3 Things You Should Know About the GA Pipeline
September 18th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Kalaris enrolling phase 1b/2 study of TH103 for nAMD
September 18th 2025

Kalaris enrolling phase 1b/2 study of TH103 for nAMD

Ollin Biosciences announces its official launch
September 18th 2025

Ollin Biosciences announces its official launch

© 2025 MJH Life Sciences

All rights reserved.